Multigene amplification and massively parallel sequencing for cancer mutation discovery. 2007

Fredrik Dahl, and Johan Stenberg, and Simon Fredriksson, and Katrina Welch, and Michael Zhang, and Mats Nilsson, and David Bicknell, and Walter F Bodmer, and Ronald W Davis, and Hanlee Ji
Stanford Genome Technology Center, Stanford University, Palo Alto, CA 94304, USA. fdahl@stanford.edu

We have developed a procedure for massively parallel resequencing of multiple human genes by combining a highly multiplexed and target-specific amplification process with a high-throughput parallel sequencing technology. The amplification process is based on oligonucleotide constructs, called selectors, that guide the circularization of specific DNA target regions. Subsequently, the circularized target sequences are amplified in multiplex and analyzed by using a highly parallel sequencing-by-synthesis technology. As a proof-of-concept study, we demonstrate parallel resequencing of 10 cancer genes covering 177 exons with average sequence coverage per sample of 93%. Seven cancer cell lines and one normal genomic DNA sample were studied with multiple mutations and polymorphisms identified among the 10 genes. Mutations and polymorphisms in the TP53 gene were confirmed by traditional sequencing.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D005820 Genetic Testing Detection of a MUTATION; GENOTYPE; KARYOTYPE; or specific ALLELES associated with genetic traits, heritable diseases, or predisposition to a disease, or that may lead to the disease in descendants. It includes prenatal genetic testing. Genetic Predisposition Testing,Genetic Screening,Predictive Genetic Testing,Predictive Testing, Genetic,Testing, Genetic Predisposition,Genetic Predictive Testing,Genetic Screenings,Genetic Testing, Predictive,Predisposition Testing, Genetic,Screening, Genetic,Screenings, Genetic,Testing, Genetic,Testing, Genetic Predictive,Testing, Predictive Genetic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D016159 Tumor Suppressor Protein p53 Nuclear phosphoprotein encoded by the p53 gene (GENES, P53) whose normal function is to control CELL PROLIFERATION and APOPTOSIS. A mutant or absent p53 protein has been found in LEUKEMIA; OSTEOSARCOMA; LUNG CANCER; and COLORECTAL CANCER. p53 Tumor Suppressor Protein,Cellular Tumor Antigen p53,Oncoprotein p53,TP53 Protein,TRP53 Protein,p53 Antigen,pp53 Phosphoprotein,Phosphoprotein, pp53
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D052138 Genes, Neoplasm Genes whose abnormal expression, or MUTATION are associated with the development, growth, or progression of NEOPLASMS. Cancer Genes,Neoplasm Genes,Cancer Gene,Gene, Cancer,Gene, Neoplasm,Genes, Cancer,Neoplasm Gene
D021141 Nucleic Acid Amplification Techniques Laboratory techniques that involve the in-vitro synthesis of many copies of DNA or RNA from one original template. DNA Amplification Technic,DNA Amplification Technique,DNA Amplification Techniques,Nucleic Acid Amplification Technic,Nucleic Acid Amplification Technique,RNA Amplification Technic,RNA Amplification Technique,RNA Amplification Techniques,Amplification Technics, Nucleic Acid,Amplification Techniques, Nucleic Acid,DNA Amplification Technics,Nucleic Acid Amplification Technics,Nucleic Acid Amplification Test,Nucleic Acid Amplification Tests,RNA Amplification Technics,Technics, Nucleic Acid Amplification,Techniques, Nucleic Acid Amplification,Amplification Technic, DNA,Amplification Technic, RNA,Amplification Technics, DNA,Amplification Technics, RNA,Amplification Technique, DNA,Amplification Technique, RNA,Amplification Techniques, DNA,Amplification Techniques, RNA,Technic, DNA Amplification,Technic, RNA Amplification,Technics, DNA Amplification,Technics, RNA Amplification,Technique, DNA Amplification,Technique, RNA Amplification,Techniques, DNA Amplification,Techniques, RNA Amplification

Related Publications

Fredrik Dahl, and Johan Stenberg, and Simon Fredriksson, and Katrina Welch, and Michael Zhang, and Mats Nilsson, and David Bicknell, and Walter F Bodmer, and Ronald W Davis, and Hanlee Ji
January 2014, PloS one,
Fredrik Dahl, and Johan Stenberg, and Simon Fredriksson, and Katrina Welch, and Michael Zhang, and Mats Nilsson, and David Bicknell, and Walter F Bodmer, and Ronald W Davis, and Hanlee Ji
February 2016, Nucleic acids research,
Fredrik Dahl, and Johan Stenberg, and Simon Fredriksson, and Katrina Welch, and Michael Zhang, and Mats Nilsson, and David Bicknell, and Walter F Bodmer, and Ronald W Davis, and Hanlee Ji
July 2017, Scientific reports,
Fredrik Dahl, and Johan Stenberg, and Simon Fredriksson, and Katrina Welch, and Michael Zhang, and Mats Nilsson, and David Bicknell, and Walter F Bodmer, and Ronald W Davis, and Hanlee Ji
January 2009, Nature methods,
Fredrik Dahl, and Johan Stenberg, and Simon Fredriksson, and Katrina Welch, and Michael Zhang, and Mats Nilsson, and David Bicknell, and Walter F Bodmer, and Ronald W Davis, and Hanlee Ji
January 2006, Methods in molecular biology (Clifton, N.J.),
Fredrik Dahl, and Johan Stenberg, and Simon Fredriksson, and Katrina Welch, and Michael Zhang, and Mats Nilsson, and David Bicknell, and Walter F Bodmer, and Ronald W Davis, and Hanlee Ji
September 2005, Nature,
Fredrik Dahl, and Johan Stenberg, and Simon Fredriksson, and Katrina Welch, and Michael Zhang, and Mats Nilsson, and David Bicknell, and Walter F Bodmer, and Ronald W Davis, and Hanlee Ji
January 2020, Clinical chemistry,
Fredrik Dahl, and Johan Stenberg, and Simon Fredriksson, and Katrina Welch, and Michael Zhang, and Mats Nilsson, and David Bicknell, and Walter F Bodmer, and Ronald W Davis, and Hanlee Ji
July 2006, Nature medicine,
Fredrik Dahl, and Johan Stenberg, and Simon Fredriksson, and Katrina Welch, and Michael Zhang, and Mats Nilsson, and David Bicknell, and Walter F Bodmer, and Ronald W Davis, and Hanlee Ji
January 2011, Bulletin et memoires de l'Academie royale de medecine de Belgique,
Fredrik Dahl, and Johan Stenberg, and Simon Fredriksson, and Katrina Welch, and Michael Zhang, and Mats Nilsson, and David Bicknell, and Walter F Bodmer, and Ronald W Davis, and Hanlee Ji
October 2010, Human molecular genetics,
Copied contents to your clipboard!